跳至主要内容
2026全美生殖中心排名第 36 🏆 TOP 50

数据来源:Newsweek 2026 全美最佳生育诊所排名

Penn Fertility Care

US 美国
· Philadelphia
SART·Society for Assisted Reproductive Technology
member
CAP·College of American Pathologists
accredited
CLIA·Clinical Laboratory Improvement Amendments
certified
口碑
推荐
优质口碑医院,源自真实好评
2.8
44
条评价
113
人预约
立即预约
Penn Fertility Care
Penn Fertility Care 2
Penn Fertility Care 3

医院简介

Penn Fertility Care(宾夕法尼亚大学生殖中心) — 费城辅助生殖中心

机构简介

Penn Fertility Care 是宾夕法尼亚大学医疗系统(Penn Medicine)的官方辅助生殖中心,隶属于宾夕法尼亚大学佩雷尔曼医学院妇产科系生殖内分泌与不孕症专科(REI)。中心主院区位于费城大学城 3701 Market Street,配备专属生殖手术中心(Reproductive Surgical Facility)和生殖实验室。

Penn 的 IVF 项目始于 1981 年,是全美最早开展体外受精的中心之一,拥有超过 50 年 的生殖医学临床经验。据 SART 2023 Final 报告数据,该中心共完成 2,061 个 ART 周期(含 103 个胚胎银行保存周期与 352 个卵子银行保存周期),整体活产率为 40.8%。按年龄段分:<35 岁 57.7%,35–37 岁 46.4%,38–40 岁 32.2%,>40 岁 12.6%

该中心是美国国立儿童健康与人类发展研究所(NICHD)指定的全美 8 所生殖医学中心(Reproductive Medicine Unit, RMU) 之一,专注于不孕症治疗的客观评估和新方法的开发。中心还设有生育力保存项目,为癌症患者等需要保护生育能力的群体提供冻卵、冻精及胚胎冷冻服务。

荣誉与成就

全美首批 IVF 中心之一:Penn 的 IVF 项目成立于 1981 年,是继 1978 年全球首例试管婴儿诞生后,美国最早开展该技术的学术医疗中心之一。

NIH 指定生殖医学中心(RMU):全美仅 8 家获 NICHD 指定的生殖医学单位之一,负责评估和开发新的不孕症治疗方法。

SART 2023 年度 2,061 个 ART 周期:作为宾夕法尼亚州规模最大的学术型 IVF 项目之一,<35 岁患者累积活产率达 57.7%(SART 2023 Final)。

Penn Medicine 系统支持:依托宾夕法尼亚大学医疗系统的多学科资源,包括三所主要医院(HUP、宾夕法尼亚医院、宾夕法尼亚长老会医院)和数百个门诊中心。

50 年以上生殖医学创新历史:在显微外科、腹腔镜手术和辅助生殖技术方面拥有国际公认的创新成果。

核心优势

  • 学术医疗中心的专业保障:作为佩雷尔曼医学院的教学医院,所有 REI 医师均具备生殖内分泌与不孕症专科认证,同时承担 NIH 资助的前沿研究。
  • 专属生殖手术中心和实验室:中心拥有独立运营的生殖手术设施和胚胎学实验室,专注于辅助生殖技术,保证实验室质量和手术效率。
  • 多院区便捷服务:在大费城地区设有三个院区(Market Street、Washington Square、Radnor),方便患者就近就诊。
  • 全面的服务范围:从基础生育力评估到 IVF、ICSI、PGT、生育力保存、卵子捐赠、LGBTQ+ 家庭建设、生殖手术等,覆盖所有辅助生殖需求。
  • 三代试管婴儿(PGT)技术:提供胚胎植入前遗传学检测,帮助降低遗传病传递风险和提升移植成功率。
  • 经济援助计划:提供 ARC Network 折扣计划、自费套餐等多种财务方案,帮助患者降低治疗费用负担。

辅助生殖服务

Penn Fertility Care 提供以下辅助生殖服务:

  • 体外受精(IVF):配备高规格胚胎实验室,每年完成数百个 IVF 周期
  • ICSI 单精子注射:针对男性因素不孕症
  • 胚胎植入前遗传学检测(PGT-A/PGT-M):染色体非整倍体筛查及单基因病检测
  • 卵子冷冻(生育力保存):为医学原因(如癌症治疗)或个人原因需要保存生育能力的患者
  • 胚胎冷冻与冷冻胚胎移植(FET)
  • 捐卵项目:提供新鲜和冷冻卵子捐赠周期
  • 第三方辅助生殖(Gestational Carrier)
  • LGBTQ+ 家庭建设:为同性伴侣和跨性别者提供专属生育方案
  • 生殖内分泌手术:宫腔镜、腹腔镜等微创生殖手术
  • 多囊卵巢综合征(PCOS)专科管理
  • 男性不育评估与治疗

费用参考

Penn Fertility Care 未在官网公开 IVF 治疗的具体套餐价格。费用因个体治疗方案、药物选择及保险覆盖范围而异。中心设有财务顾问团队,协助患者了解保险福利并提供自费套餐和 ARC Network 折扣计划等选项。

就诊流程

初诊咨询:可通过线上预约或电话预约进行初诊咨询,中心支持远程视频问诊(Telemedicine),方便外州或国际患者先行线上评估。

生育力评估:就诊时医生将进行全面生育力评估,包括激素水平检测、卵巢储备功能评估(AMH、基础卵泡数)、精液分析及影像学检查等,以明确不孕原因。

个性化方案制定:根据评估结果,REI 专科医生将制定个性化治疗计划(IVF、IUI、药物促排卵、手术等),并与患者详细讨论各方案的成功率、风险和费用。

周期治疗:确定方案后进入正式治疗周期,包括促排卵(约 8–14 天)、取卵手术(门诊手术,静脉麻醉下进行)、体外受精与胚胎培养(3–6 天)、胚胎移植或冷冻保存。

胚胎移植与妊娠确认:移植后约 10–14 天通过血液 HCG 检测确认是否妊娠,妊娠后继续黄体支持至 8–10 周后转入常规产科随访。

当地法律说明

Pennsylvania IVF 法律保障

宾夕法尼亚州对辅助生殖技术的法律框架较为完善,认可善意代孕协议(Gestational Carrier Agreement)。该州未对 IVF、胚胎冷冻或 PGT 设置明确的年龄上限或特定限制,但各医疗机构的政策可能有所差异。Penn Fertility Care 为患者提供第三方辅助生殖服务(包括卵子捐赠和 gestational carrier),具体法律安排建议咨询专业生殖法律顾问。

州法律未强制要求保险覆盖不孕症治疗,但部分雇主提供的商业保险计划可能包含一定的生育治疗福利。中心的财务顾问可协助患者了解具体保险条款。

核心优势

IVF试管
PGT-A基因筛查
LGBT友好

医院位置

3701 Market St, 8th Floor, Suite 800, Philadelphia, PA 19104

配套设施

无障碍通道
停车服务
多语言服务

医疗团队

用户评价

2.8
44条评价
5星
65%
4星
20%
3星
8%
2星
4%
1星
3%
O
Oleksandr Zaytsev
1 周前

自2020年以来,我们全家一直是PennMed的患者,在其他合作机构的就诊体验总体上是积极的。这篇评论反映了我们在Penn Fertility Care就诊的个人经历,涉及已知遗传风险的FMR1/脆性X综合征、试管婴儿和PGT-M治疗。在开始治疗前,我们询问诊所是否有处理脆性X综合征病例的实践经验。他们告诉我们有,我们的病例由Anuja Dokras医生负责。所有5次咨询都是线上进行的;偶尔会出现技术延迟,其中一次持续了约40分钟。两次预约之间间隔1-3个月,这让我们感觉时间有限,难以讨论复杂的遗传问题,也难以在不确定性中充分了解下一步的治疗方案。我们曾两次要求更换医生(初诊时和早期,并指定了医生),但都被拒绝了(见附件)。在遗传咨询和两个促排卵周期后,我们对使用自身卵子获得健康、可移植胚胎的现实可能性产生了严重的疑问。第一个周期:取卵16个。第一次取卵,形成2个胚胎,但均未通过PGT-A检测。第二次取卵:取卵14个,形成1个携带完全突变的胚胎。在多次询问后,当医生提出进行第三次试管婴儿周期时,我们才得到一个针对每个周期约10%的成功率估计。考虑到约50%的胚胎移植成功率、实验室冻融风险,以及133重复的母源前突变有94%以上的概率扩展为完全突变(这排除了移植携带女性基因的胚胎的可能性——这一点事先并未明确说明),累积的成功率极低。在没有充分咨询的情况下,不惜一切代价,在不确定的时间内追求一个健康的胚胎,感觉是一个不可行的策略。我们尊重临床判断,也知道试管婴儿并不能保证特定的结果。然而,我们缺乏早期、清晰的解释,来了解年龄、FMR1前突变以及PGT-A/PGT-M结果如何共同影响我们的预后。我们需要一次及时、坦诚的讨论。在经历两个昂贵且耗费精力的试管婴儿周期之前,如果能了解其他选择,包括捐卵,或许可以避免我们承受如此沉重的经济和精神负担。我们与诊所领导会面,就策略和沟通方面提出了疑问。他们向我们展示了遗传学提供的试管婴儿通用统计数据;然而,我们认为这些通用数据并不能反映我们复杂的情况。诊所提出以行政费用为由,部分补偿我们2500美元。虽然我们对此表示感谢,但这并没有解决我们最核心的问题——沟通不畅和个性化方案。这篇评论并非正式的医疗事故指控,而是一份坦诚的叙述。宾夕法尼亚大学生育护理中心,医生。 Anuja Dokras 和宾夕法尼亚大学医院 (HUP) 患者体验部门在改善个体化预后解释、早期讨论治疗方案以及在复杂遗传病例中营造同理心沟通文化方面具有真正的潜力。我们始终保持开放的对话态度,并已向宾夕法尼亚大学医学院的首席执行官和副总裁发送了一封附有完整文件的信函,要求对基于不完整知情同意的医疗费用进行独立申诉审查并寻求公平的解决方案。其他问题:胚胎储存:即使无法使用,材料也默认冷冻保存;我们是在收到账单后才得知存在费用。在第二个周期中,我们不得不主动提交文件以停止对受影响胚胎的储存(见附件)。手术:在一次随访中,一名住院医师两次尝试插入导管均未成功,导致患者不适,直到主治医师完成操作。已记录并与领导层讨论。财务部门:非常规申请需要 2-4 周时间,并且需要反复跟进。一份雇主补助金的基本明细账单也出现了严重的延误。尽管我们的个人信用利率远低于此,但我们还是被推荐到ARC Fertility(年利率13-18%)。反复出现的账单错误导致保险公司不得不进行审核。在预付款之前,我们收到了错误的合同包,这引发了协调方面的问题(见附件)。这损害了我们对诊所的信任。我们给予两星评价,以表彰那些展现出卓越同理心和关怀的敬业护士、临床工作人员和医生。新的视角和积极的领导力能够真正推动诊所的改进。衷心感谢Kathleen O'Neill医生、Marissa Weiss医生、Alexandra Taylor医生、Laura Swartz、手术室护士以及前台团队。

Our family has been patients with PennMed since 2020,& at other network locations,our experience has generally been positive.The review reflects our personal experience at Penn Fertility Care regarding family planning with a known genetic risk FMR1/Fragile X syndrome,IVF,PGT-M.Before starting treatment,we asked whether the clinic had practical experience managing Fragile X cases.We were told they did,& our case was handled by Dr. Anuja Dokras.All 5 consultations were virtual;there were occasional tech delays, one lasting ~40 mins.Between appts,1–3 mos would pass, leaving us feeling we had limited time to discuss complex genetic questions & fully understand next steps amid uncertainty.We twice asked to switch MDs (at intake & early on, requesting a specific doctor), but were declined (see att.).After genetic counseling & 2 stimul cycles,we had serious questions about realistic chances of obtaining a healthy,transferable embryo with our own eggs.Cycle1:16 eggs retrieved,2 embryos formed,neither passed PGT-A.Cycle 2:14 eggs retrieved,1 embryo formed with the full mutation.Only after repeated inquiries,when a 3 cycle was proposed,did we receive an individualized estimate~10% chance per cycle.Factoring in~50% embryo transfer success rates,lab freeze/thaw risks,and the 94%+ probability that a 133-repeat maternal premutation expands to a full mutation (which eliminated transferring a female carrier embryo—something not clarified upfront),the cumulative odds were critically low.Pursuing 1 healthy embryo at any financial cost over an open-ended timeline felt like an unviable strategy without full upfront counseling.We respect clinical judgment & know IVF guarantees no specific outcome.However,we lacked an early,clearly explained picture of how age,the FMR1 premutation,& PGT-A/PGT-M results collectively affected our prognosis.A timely, candid discussion of alternatives,including donor eggs,before undergoing 2 costly,demanding cycles,could have spared us a heavy financial & emotional toll.Meeting with clinic leadership, we raised questions regarding strategy & communication.We were shown general IVF stats from genetics;however,we felt these generic figures didn't reflect our complex case.We were offered a $2,500 partial reimbursement for admin issues.While grateful for the gesture,it did not address our core concern-communication gaps& personalized planning.This review is not a claim of formal medical error, but a candid account.Penn Fertility Care,Dr. Anuja Dokras,& the HUP Patient Experience dept have real potential to improve how individualized prognoses are explained, how options are discussed early,& the culture of empathetic communication in complex genetic cases.We remain open to dialogue & sent a letter with full documentation to Penn Med's CEO & VPs,requesting an independent grievance review & fair resolution regarding fair reimbursement for care based on incomplete informed consent.Additional issues:Embryo storage: materials kept in cryo by default even when unusable;we learned about active fees only after an invoice. In cycle 2, we had to proactively file paperwork to stop storage of the affected embryo (see att.)Procedure: during a follow‑up,a fellow attempted catheter insertion twice unsuccessfully,causing discomfort until an attending MD completed it.Documented + discussed with leadership.Finance dept: non‑routine requests took 2–4 wks + repeated follow‑ups.A basic itemized bill for an employer grant had major delays. We were referred to ARC Fertility (13–18% APR) despite much lower personal credit rates.Recurring billing errors required insurance audits.Before prepayment,we received the wrong contract pkg,raising coordination concerns (see att.)This damaged trust.We give 2 stars to recognize dedicated nurses,clinical staff,& individual physicians who showed outstanding empathy & care.Fresh perspectives & positive leadership can drive real clinic improvement.Sincere thanks to Dr. Kathleen O'Neill,Dr. Marissa Weiss,Dr. Alexandra Taylor,Laura Swartz,procedure room nurses,& the front desk team.

A
Ashley Fioravanti
1 个月前

没有无障碍检查台。纯粹是贪婪,连个升级的电动升降检查台都没有。做检查的时候感觉很不安全,因为我有肌肉萎缩症,我丈夫不得不把我抬上检查台。

No accessible exam table. Pure greed to not have an updated electric raising exam table. Felt very unsafe getting an exam and my husband had to lift me on the table because I have muscular dystrophy.

A
Amanda B
3 个月前

在整个艰难的求子过程中,这家诊所给予了我极大的支持和帮助。在开始我的生育之旅前,我的医生发现我有一个卵巢囊肿,需要切除。奥尼尔医生在整个过程中都非常和蔼体贴。不幸的是,术后我出现了感染,奥尼尔医生和诊所的护士们都非常热心,给予了我很多帮助。他们给了我很多医疗用品来帮助我康复。在整个过程中,我接触过的每一位医护人员都非常棒!他们都耐心解答了我的所有问题,而且非常热情友好,我觉得在这种环境下这一点尤为重要。我完全信任我的医护人员,感觉他们和我一样渴望成功。诊所通过门户网站回复也很及时。每次我发送消息,德文尼都会很快回复,而且回复内容详尽、态度亲切。前台和其他办公室工作人员也都非常棒。有一次,在预约期间,诊所人手不足,有些延误,他们还为我们提供了零食和饮料,让我们在等待的时候享用。我个人非常推荐这家诊所。特别是如果您患有多囊卵巢综合征,并且希望找到对多囊卵巢综合征非常了解的医疗服务提供者。

I've found this clinic to be very supportive and helpful throughout this difficult process. Prior to starting my fertility journey, my doctor found an ovarian cyst that had to be removed. Dr. O'Neil was kind and thoughtful throughout that process. I unfortunately had an infection after surgery, and Dr O'Neil was very helpful and attentive as well as the nurses on staff. They gave me a lot of supplies to help heal my infection. Throughout this process every provider I've worked with has been amazing! They all answered my questions, and have been just very warm and welcoming which I feel like is very important in this setting. I trust my providers wholeheartedly and feel like they want this to succeed as much as I do. The clinic has also been very responsive through the portal. Whenever I send a message, Devenne responds very quickly with a thorough and kind response. The front desk staff and other office staff have been great, too. One day, during an appointment, the clinic was understaffed and running behind, and they provided snacks and drinks while we waited. Personally, I would recommend this clinic. Especially if you have PCOS and want providers that are very informed on PCOS.

E
Enrique Vargas
4 个月前

我和妻子这次就医体验非常好。护士们解释得非常清楚,让我们全程都感到很放松。手术团队术后还来查看我们的情况,甚至还开了些玩笑,这真的让我们安心了不少。总而言之,我们感觉受到了很好的照顾。

My wife and I had a great experience. The nurses explained everything clearly and made us feel comfortable the whole time. The surgical team checked on us afterward and even joked around a bit, which really helped ease the nerves. Overall, we felt well taken care of.

A
Alexandra Wilkins
5 个月前

凯特琳·马丁医生是我和我丈夫见过的最冷漠、最缺乏同情心、最不讲道理的“专业人士”之一。我简直无法理解她怎么还能在这家诊所工作,还能继续接收新病人——如果你正在考虑找她,那就赶紧远离她的“治疗”。我和我丈夫一年来可能只跟她说过三次话,其中一次还是在做试管婴儿期间,她打电话来对我大吼大叫。她没有后续跟进,没有祝贺我们怀孕,还百般刁难我的新妇产科医生,让我很难拿到病历。总而言之,她简直是医学界的耻辱。

Dr. Caitlin Martin is one of the most transactional, cold, and lacking in every form of compassion "professionals" my husband and I have ever worked with. How she is employed by this facility and continues to take on new patients is beyond…...

E
Emily SchiffEm
已编辑:6 个月前

更新:沟通不畅的情况依然存在,他们回复中的链接无法打开。很遗憾,我并不感到意外。 我的医生和超声波技师都很友善。但不幸的是,我遇到了很多问题,财务、护士和前台工作人员都提供了不准确的信息和误导性的信息。 如果你住在新泽西州,我强烈推荐RMA而不是宾夕法尼亚大学。宾夕法尼亚大学生育中心在新泽西州没有办公室,也没有宾夕法尼亚大学的药房。 我觉得我的很多护理都没有个性化,而且第一次就获得准确信息几乎是不可能的。 取卵后我出现了严重的并发症,住院数日。虽然我理解这是已知的风险,但宾夕法尼亚大学之后的沟通简直糟糕透顶。他们寄给我一封挂号信,内容含糊不清,令人困惑。信里给了我几个联系人的姓名和电话号码,但最终我一个也没联系上。工作人员基本上是这么告诉我的:“州政府要求我们寄那封信,你不需要采取任何行动。” 如果你不打算让患者与他们联系,就不要向患者提供后续联系的联系方式和电话号码。

UPDATE: The poor communication continues, the link in their reply below does not work. I'm not surprised unfortunately. My dr and the ultrasound techs were very kind. Unfortunately I ran into a lot of issues with being given inaccurate information and misinformation coming from finance, nurses and front desk staff. Ultimately if you live in NJ I'd highly recommend RMA over Penn. Penn fertility does not have any offices in New Jersey, nor are there any Penn pharmacies. I felt like a lot of my care was not personalized and getting accurate information the first time around was impossible. I also had a major complication after my egg retrieval and ended up in the hospital for days. While I understand that this is a known risk, the communication afterwards from Penn was nothing short of terrible. I was sent a certified letter that was very nondescript and confusing. I was provided with several names and phone numbers to follow up with, and in the end was not able to speak with any of them. I was essentially told by staff " The state just makes us send that letter. You don't need to take any action". Don't provide patients with a communication and phone numbers to follow up with if you don't intend to allow that patient to speak with them.

J
Janine Beckles
1 年前

这是我人生中最糟糕的经历,他们也不清楚我的身体或AMH水平到底出了什么问题。

The worst experience of my life and they were not clear what was going on with my body or AMH levels.

A
Andrea Collins
10 个月前

我最初的咨询过于乐观,低估了我诊断结果的统计现实。财务顾问也没有清楚地说明我可能需要多次治疗的可能性很高。这种不切实际的希望让最终的阴性结果更加令人沮丧。

My initial consultation was overly optimistic, downplaying the statistical reality for my diagnosis. The financial counselor wasn't clear about the high likelihood of needing multiple cycles. This false hope made the eventual negative result even more crushing.

P
Paula Whitaker
10 个月前

我们感觉自己就像工厂里的一个数字。第二次治疗失败后,治疗方案没有任何改变,也没有进行彻底的复查。医生很匆忙,记不清我们的具体情况,让原本充满情感的过程变得冷漠而例行公事。

We felt like a number in a factory. After our second failed cycle, there was no change to our protocol or a thorough review. The doctor was rushed and didn't recall our specific case details, making an emotional process feel cold and transactional.

Y
Yang X
已编辑:1 年前

人们通常会认为,与宾夕法尼亚大学(Penn)相关的机构应该秉持最高标准——但遗憾的是,我的经历并非如此。 我曾在该机构接受取卵手术。成熟卵子的数量远低于我这个年龄段女性的平均水平。尽管他们保证会在第二次尝试中做出调整,但结果依然没有改变。鉴于我的经历,这种毫无改进的情况让我对他们进行这项手术的专业水平产生了怀疑。我要求他们提供取卵图像以及12月份试管婴儿会议的反馈意见作为证据,但至今未收到任何回复。 除了结果不尽如人意之外,医护人员还存在疏忽。第一次尝试时,他们没有给我开促排卵针的药物。直到我预约注射当天,我才发现这一点。这迫使我匆忙赶到宾夕法尼亚大学医院(HUP)的药房(2023年8月21日),几乎是在药房关门前才拿到药。 第二次尝试时也遇到了类似的挫折,关于注射亮丙瑞林(Lupron)的说明令人困惑。不仅没有解释剂量单位,也没有明确说明从药房收到的亮丙瑞林是可以直接使用还是需要稀释。由于注射时间紧迫,这种不明确的说明迫使我紧急致电。我是一名生物医学研究人员,不得不运用自己的专业知识来判断2023年11月9日的用药情况。 2024年3月18日,我还就所有不愉快的经历向患者及客户关系部门提交了投诉。虽然我收到了他们确认收到投诉的邮件,但却没有任何回复! 整个流程似乎缺乏足够的监管,这令人担忧。患者仍然被收取高额费用——例如,由于上一轮治疗效果不佳,可能需要额外治疗,而患者却被收取了7000美元的费用。除非患者愿意采取法律行动,否则似乎很难追究他们的不当行为。 如果您还有其他选择,我希望这条评论至少能帮助您决定去哪里接受生育治疗。 以下是我对宾夕法尼亚大学生育中心回复的评论: ---------------------------------------------------------------- 感谢您的回复,但我想再次强调一点。 我去年确实通过您提供的链接提交了所有信息。虽然我收到了确认邮件,但之后却没有人真正处理此事。 所以,我不得不说:这个患者/客户关系网站毫无用处,没有人会真正解决实际问题。 追究你们责任的唯一方法可能就是提起诉讼,但很多人都负担不起!

One would expect a place associated with the name Penn to uphold the highest standards—but unfortunately, that has not been my experience. I underwent egg retrieval procedures with them. The number of mature eggs fell significantly below the expected average for women of my age. Despite assurances of adjustments for the second attempt, the outcome remained unchanged. This lack of improvement has raised doubts regarding their level of expertise in performing this procedure, given my experience. I requested evidence in the form of images of the retrieved eggs and feedback from the IVF meeting in December, but I didn’t received response. In addition to the unsatisfactory results, there were instances of negligence from the providers. During the first attempt, the drug for the trigger shot was not initially prescribed. I found out on the day I was scheduled for the shot. This necessitated a frantic last-minute trip to the HUP pharmacy (8/21/2023), barely obtaining the medication before closing time of the HUP pharmacy. A similar frustration also happened during the second attempt, the instructions regarding the injection of Lupron was confusing. Not only was the unit measurement left unexplained, but clarity on whether the Lupron received from the pharmacy was ready for use or required dilution was also lacking. As the injection was time sensitive, this lack of clarity forced me to make an urgent call. I am a biomedical researcher, and I had to use my own professional knowledge to reason the usage on November 9, 2023 I also filed a complaint at Patient & Guest Relations representative about all of my unsatisfactory experience on Mar.18 2024. Although I received their confirmation of receiving my complaint, but I didn’t received any response!! It is concerning that the entire process appears to lack adequate oversight. Patients continue to be charged substantial amounts—such as the $7,000 fee for potential additional rounds, due to the unsatisfactory outcome in the previous round. Unless the patient is willing to pursue legal action, it seems there is little recourse to hold them accountable for their misconduct. I hope this comment can at least help you decided where to go for fertility care if you have other options. Below are my comments to the reply of Penn Fertility Care: ---------------------------------------------------------------- thank you for your response, but let me emphasize this again. I did write everything last year using the link you provided. Although I receive a confirmation email, but no one actually process the issue afterwards. So, I have to say this: this patients/guest-relations website is useless and no one will really take care of the actual issues. The only way to hold you accountable probably would be an legal action, which many people can't afford!

以上为最新 10 条评价,共 44 条

相关文章

准备好开始您的生育之旅了吗?

专业医疗顾问为您提供个性化方案建议

免费咨询